Medtronic CGM

Medtronic Continuous Glucose Monitoring System

Avoid Highs and Lows with a Medtronic CGM!

Medtronic Guardian™ Connect CGM

Medtronic Guardian Connect CGM is the world’s first Smart Continuous Glucose Monitoring (CGM)* system for people on insulin injections. With breakthrough tools to outsmart the highs and lows of diabetes, the Guardian Connect CGM allows you to focus on your life — not on your levels. Using smart technology to predict where your glucose levels are headed, the system will alert you from 10 to 60 minutes before a high or low.

 

Customizable glucose alerts built for you

Real-time glucose trends through the app

Updates glucose data every 5 minutes

Can be used for Type 1 or Type 2 diabetes

———- Discover More ———-

Introducing the Guardian Connect

Guardian Connect: Have More Good Days

What is a CGM?

Do I need a prescription for the Guardian Connect CGM system?

The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes.

Will my insurance cover the Guardian Connect CGM?

Once you have enrolled, your dedicated Diabetes Care Advisor (DCA) will verify your insurance benefits and obtain a prescription from your physician. Within two business days, your DCA will contact you to explain your options and go over everything you need. We handle all necessary paperwork between your insurance and your healthcare team, keeping you updated every step of the way.

Does the Guardian Connect system integrate with the Medtronic insulin pumps?

The MiniMed 600-series pumps use the Guardian Link 3 transmitter, which uses a different wireless technology to communicate with the pump. The transmitter shell for the Guardian Connect system also has a “GC” etched on the surface opposed to the pump system transmitter shell, which just has a “G.”

*The Guardian Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus.

*The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

*Alerts must be set to receive predictive alerts.

 

Your Cart